MediciNova to Present at the Rodman and Renshaw Annual Global Investment Conference

SAN DIEGO, Sept. 2, 2010 GLOBE NEWSWIRE — MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market Nasdaq:MNOV and the Hercules Market of the Osaka Securities Exchange Code Number: 4875, today announced that Shintaro Asako, Chief Financial Officer of MediciNova, will present a company overview at the Rodman and Renshaw [...] http://bit.ly/aT5tch